China SXT Pharmaceuticals... (SXTC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.38
-0.04 (-9.16%)
At close: Jan 15, 2025, 12:35 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -3.10M | -5.93M | -5.74M | -2.75M | -10.29M | 1.54M | 1.19M | 1.19M | 141.54K |
Depreciation & Amortization | 203.25K | 250.16K | 320.01K | 345.41K | 331.84K | 180.92K | 129.44K | 99.23K | 88.96K |
Stock-Based Compensation | 352.10K | 554.57K | 2.33M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 159.41K | 83.91K | 1.28M | -506.08K | 1.50M | 660.63K | -467.63K | 1.04M | 1.09M |
Other Non-Cash Items | 996.69K | 408.69K | 1.12M | 1.62M | 3.35M | 66.89K | -2 | 1.44M | 1.34M |
Deferred Income Tax | n/a | 3.23M | 328.15K | -192.68K | -101.72K | -7.72K | -5.85K | n/a | n/a |
Change in Working Capital | -381.56K | 1.42M | 1.90M | -1.61M | 1.95M | -1.54M | 608.99K | -991.33K | -58.63K |
Operating Cash Flow | -1.93M | -80.76K | 268.29K | -1.32M | 934.25K | 239.19K | 1.92M | 293.04K | 182.47K |
Capital Expenditures | -7.06K | -70.68K | -62.49K | -93.04K | -406.66K | -610.09K | -1.05M | -186.31K | -96.99K |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.23K |
Purchase of Investments | n/a | n/a | n/a | -8.85M | -3.59M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 33.49K | 58.38K | 15.58K | 3.13M | -1.50M | -11.28K | -92.42K | -7.13K | -36.04K |
Investing Cash Flow | 26.42K | -12.30K | -46.91K | -5.81M | -5.50M | -610.09K | -1.14M | -186.31K | -95.76K |
Debt Repayment | 1.31M | 4.00M | 2.77M | -124.95K | 8.80M | 69.49K | -314.22K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.93M | -3.26M | -4.29M | 12.53M | -5.78M | 2.48M | n/a | -50.56K | -128.59K |
Financial Cash Flow | -2.62M | 2.94M | 1.60M | 12.41M | 3.02M | 9.04M | -314.22K | -50.56K | -128.59K |
Net Cash Flow | -5.29M | 1.80M | 2.21M | 6.07M | -2.00M | 8.63M | 494.68K | 54.13K | -43.91K |
Free Cash Flow | -1.94M | -151.44K | 205.80K | -1.41M | 527.59K | -370.89K | 869.44K | 106.73K | 85.48K |